You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MZL

Showing 26 - 50 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin Trial in Germany, Puerto Rico, United States (Lenalidomide, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +114 more
Jan 11, 2023

B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

Not yet recruiting
  • B-cell Non-Hodgkin's Lymphoma
  • (no location specified)
Mar 6, 2023

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
Nov 4, 2022

B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +3 more
Sep 26, 2021

B-cell Non-Hodgkin Lymphoma (NHL) Trial in Worldwide (Odronextamab)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (NHL)
  • Chicago, Illinois
  • +122 more
Apr 1, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

Not yet recruiting
  • Follicular Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) Trial in France (Real-life

Recruiting
  • Diffuse Large B Lymphoma (DLBCL)
  • +6 more
  • Real-life epidemiological platform of lymphoma in France
  • Arras, France
  • +36 more
Jun 25, 2021

Hematologic Cancer Trial in Israel, United States (ABBV-101)

Not yet recruiting
  • Hematologic Cancer
  • Lone Tree, Colorado
  • +7 more
Feb 22, 2023

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)

Recruiting
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • EO2463
  • +2 more
  • Boston, Massachusetts
  • +9 more
Jul 26, 2022

Marginal Zone Lymphoma, Follicular Lymphoma Trial in China (HMPL-689)

Recruiting
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • Hefei, Anhui, China
  • +35 more
Jun 7, 2021

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Tucson, Arizona
  • +134 more
Jul 27, 2022

Lymphomas Trial in Wuhan, Guangzhou, Shanghai (HMPL-689)

Active, not recruiting
  • Lymphomas
  • Wuhan, Hubei, China
  • +2 more
Sep 8, 2022

B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Loncastuximab Tesirine
  • +4 more
  • Pembroke Pines, Florida
  • +19 more
Jul 22, 2022

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

Recruiting
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
  • +5 more
  • Duarte, California
  • +12 more
Jun 16, 2022

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma
  • Phoenix, Arizona
  • +36 more
Jul 28, 2022

Non-Hodgkin Lymphoma Trial in Switzerland (Copanlisib, Venetoclax)

Terminated
  • Non-Hodgkin Lymphoma
  • Basel, Switzerland
  • +5 more
Mar 18, 2022

Relapsed/Refractory B-cell Malignancies Trial (AC676)

Not yet recruiting
  • Relapsed/Refractory B-cell Malignancies
  • (no location specified)
Mar 27, 2023

CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

Recruiting
  • CLL/SLL
  • +6 more
  • Cincinnati, Ohio
  • +2 more
May 7, 2022

Marginal Zone Lymphoma Trial in Miami (Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg)

Recruiting
  • Marginal Zone Lymphoma
  • Loncastuximab tesirine 150 µg/Kg
  • Loncastuximab tesirine 75µg/Kg
  • Miami, Florida
    University of Miami
Jul 12, 2022

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

Recruiting
  • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
  • Columbus, Ohio
  • +9 more
Aug 1, 2022

Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
Oct 3, 2022

Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

Recruiting
  • Mature B-Cell Malignancies
  • Stanford, California
  • +26 more
Dec 16, 2021

Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

Recruiting
  • Marginal Zone Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 15, 2021